Rubicon's PicoPlex Amplification Technology Validated for Single-Cell IVF Analysis in ESHRE Study

The results not only have the potential to improve the chances of pregnancy for couples undergoing IVF, but also point toward opportunities for research and diagnostic testing of single cancer cells and stem cells, according to a Rubicon official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.